Benefits and costs of substance abuse treatment programs for state prison inmates: Results from a lifetime simulation model

Health Economics

Volumn 21, Issue 6, 2012, Pages 633-652

  Zarkin, Gary A ^a   Cowell, Alexander J ^a   Hicks, Katherine A ^a   Mills, Michael J ^a   Belenko, Steven ^b   Dunlap, Laura J ^a   Houser, Kimberly A ^b   Keyes, Vince ^a  

^a RTI INTERNATIONAL   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

benefits; costs; inmates; simulation; substance abuse treatment

Indexed keywords

ADULT; AFTERCARE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; CRIME; CRIMINAL JUSTICE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRISON; PRISONER; SIMULATION;

ADULT; AGE FACTORS; COST SAVINGS; COST-BENEFIT ANALYSIS; CRIMINAL LAW; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; PRISONS; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84860230403     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1735     Document Type: Article

References (63)

1. Auerhahn K., 2004. California's incarcerated drug offender population, yesterday, today, and tomorrow: evaluating the war on drugs and Proposition 36. Journal of Drug Issues 34 (1): 95-120. (Pubitemid 38451866)
2. Auerhahn K., 2008a. Dynamic systems simulation analysis: a planning tool for the new century. Journal of Criminal Justice 36 (4): 293-300.
3. Auerhahn K., 2008b. Using simulation modeling to evaluate sentencing reform in California: choosing the future. Journal of Experimental Criminology 4: 241-266.
4. Belenko S., 2002. Trends in substance abuse and treatment needs among inmates: final report. Report 197073, Report to National Institute of Justice by the National Center on Addiction and Substance Abuse at Columbia University, Department of Justice.
5. Belenko S, Peugh J., 2005. Estimating drug treatment needs among state prison inmates. Drug and Alcohol Dependence 77: 269-281. (Pubitemid 40283529)
6. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD,. 2007. Release from prison-a high risk of death for former inmates. The New England Journal of Medicine 356 (2): 157-165. (Pubitemid 46089676)
7. Brady JE, Friedman SR, Cooper HLF, Flom PL, Tempalski B, Gostnell K., 2008. Estimating the prevalence of injection drug users in the U. S. in large U. S. metropolitan areas from 1992 to 2002. Journal of Urban Health 85 (3): 323-351.
8. Bureau of Justice Statistics (BJS). 2006. Justice expenditure and employment extracts, 2004. Justice system expenditure by character, state and type of government, fiscal year 2004. Bureau of Justice Statistics Bulletin, NCJ 215648, U.S. Department of Justice, Office of Justice Programs, Washington, DC. (Available from:.)
9. Butzin CA, Martin SS, Inciardi JA., 2002. Evaluating component effects of a prison-based treatment continuum. Journal of Substance Abuse Treatment 22: 63-69. (Pubitemid 34257981)
10. Butzin CA, Martin SS, Inciardi JA., 2005. Treatment during transition from prison to community and subsequent illicit drug use. Journal of Substance Abuse Treatment 28: 351-358. (Pubitemid 40733144)
11. Centers for Disease Control and Prevention (CDC). 2008. HIV/AIDS Surveillance Report, 2006, Vol. 18, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Atlanta, GA. (Available from:.)
12. Chaiken JM, Chaiken MR., 1982. Varieties of Criminal Behavior. Rand Corporation: Santa Monica, CA.
13. Chandler RK, Fletcher BW, Volkow ND., 2009. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. Journal of the American Medical Association 301 (2): 183-190.
14. Cohen MA, Miller TR, Rossman SB., 1994. The costs and consequences of violent behavior in the United States. In Understanding and Preventing Violence, Volume 4: Consequences and Control, Reiss Jr AJ, Roth JA, (eds). Committee on Law and Justice, Commission on Behavioral and Social Sciences and Education, National Research Council, National Academy Press: Washington, DC.
15. Daley M, Love CT, Shepard DS, Petersen CB, White KL, Hall FB., 2004. Cost-effectiveness of Connecticut's in-prison substance abuse treatment. Journal of Offender Rehabilitation 39 (3): 69-92. (Pubitemid 39473840)
16. Durose MR, Langan PA., 2004. Felony sentences in State Courts, 2002. Bureau of Justice Statistics Bulletin, NCJ 206916, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
17. Earnshaw SR, Joshi AV, Wilson MR, Rosand J., 2006. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke 37: 2751-2758. (Pubitemid 44929415)
18. Federal Bureau of Investigation (FBI). 2005. Crime in the United States, 2004. U.S. Government Printing Office: Washington, DC.
19. Florida Department of Corrections. 2005. Substance Abuse Report-Inmate Programs. Bureau of Research and Data Analysis & Bureau of Substance Abuse Programs: Tallahassee, FL. (Available from:.)
20. French MT, Martin RF., 1996. The costs of drug abuse consequences: a summary of research findings. Journal of Substance Abuse Treatment 13 (6): 453-466. (Pubitemid 27264291)
21. Gold MR, Siegal JE, Russell LB, Weinstein MC., 1996. Cost-Effectiveness in Health and Medicine. Oxford University Press: New York.
22. Grant BF, Moore TC, Kaplan K., 2003. Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). National Institute on Alcohol Abuse and Alcoholism: Bethesda, MD.
23. Grant BF, Kaplan KD., 2005. Source and Accuracy Statement for the Wave II National Epidemiologic Survey on Alcohol and Related Conditions. National Institute of Alcohol Abuse and Alcoholism: Bethesda, MD.
24. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Jansessen RS, for the HIV Incidence Surveillance Group. 2008. Estimation of HIV incidence in the United States. Journal of the American Medical Association 300 (5): 520-529.
25. Hamby DM., 1995. A comparison of sensitivity analysis techniques. Health Physics 68 (2): 195-204.
26. Harrison PM, Beck AJ., 2005. Prison and jail inmates at midyear 2004. Bureau of Justice Statistics Bulletin, NCJ 208801, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
27. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM., 1997. Overview of 1-year follow-up outcomes in the Drug Abuse Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (4): 261-278. (Pubitemid 28046589)
28. Inciardi JA, Martin SS, Butzin CA, Hooper RM, Harrison LD., 1997. An effective model of prison-based treatment for drug-involved offenders. Journal of Drug Issues 27 (2): 261-278. (Pubitemid 27332445)
29. Knight K, Simpson DD, Hiller ML., 1996. Evaluation of prison-based treatment and aftercare: process and outcomes. Paper Presented at the American Psychological Association, Toronto, Canada.
30. Law AM, Kelton WD., 2000. Simulation Modeling and Analysis (3rd edn). McGraw-Hill: New York, NY.
31. Mallik-Kane K, Visher CA., 2008. Health and Prisoner Reentry: How Physical, Mental, and Substance Abuse Conditions Reshape the Process of Reintegration. Urban Institute, Justice Policy Center: Washington, DC.
32. Martin SS, Butzin CA, Saum CA, Inciardi J., 1999. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: from prison to work release to aftercare. The Prison Journal 79 (3): 294-320.
33. McCollister KE, French MT., 2002. The economic cost of substance-abuse treatment in criminal justice settings. In Treatment of Drug Offenders: Policies and Issues, Leukefeld CG, Tims F, Farabee D, (eds). Springer: New York, NY.
34. McCollister KE, French MT, Inciardi J, Butzin CA, Martin SS, Hooper RM., 2003b. Post-release substance abuse treatment for criminal offenders: a cost-effectiveness analysis. Journal of Quantitative Criminology 19 (4): 389-407. (Pubitemid 39015426)
35. McCollister KE, French MT, Prendergast ML, Hall E, Sacks S., 2004. Long-term cost-effectiveness of addiction treatment for criminal offenders. Justice Quarterly 21 (2): 659-679. (Pubitemid 41717802)
36. McCollister KE, French MT, Prendergast M, Wexler H, Sacks S, Hall E., 2003a. Is in-prison treatment enough? A cost-effectiveness analysis of prison-based treatment and aftercare services for substance-abusing offenders. Law and Policy 25 (1): 63-82.
37. Michigan Department of Corrections. 2001. Substance abuse programs section. Annual Report, Fiscal Year 1999/2000, Michigan Department of Corrections, Lansing, MI.
38. Miller TR, Cohen MA, Wiersema B., 1996. Victim costs and consequences: a new look. National Institute of Justice Research Report, U.S. Department of Justice, National Institute of Justice, Washington, DC.
39. Mumola CJ, Karberg JC., 2006. Drug use and dependence, state and federal prisoners, 2004. Bureau of Justice Statistics Special Report, NCJ 213530, Revised 19 January 2007, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
40. National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) [Computer file].
41. National Institute on Drug Abuse (NIDA). 2006. Principles of Drug Abuse Treatment for Criminal Justice Populations: A Research-Based Guide. U.S. Department of Health and Human Services, National Institutes of Health: Bethesda, MD.
42. Sabol WJ, West HC, Cooper M., 2009. Prisoners in 2008. Bureau of Justice Statistics Bulletin, NCJ 228417, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
43. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage III GR, Moore RD, Freedberg KA., 2006. The lifetime cost of current Human Immunodeficiency Virus care in the United States. Medical Care 44 (11): 990-997. (Pubitemid 44674030)
44. Simpson DD., 1979. The relation of time spent in drug abuse treatment to posttreatment outcome. American Journal of Psychiatry 136 (11): 1449-1453. (Pubitemid 10189032)
45. Simpson DD, Joe GW, Brown BS., 1997. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (4): 294-307. (Pubitemid 28046591)
46. Stephan JJ., 2004. State prison expenditures, 2001. Bureau of Justice Statistics, NCJ 202949, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
47. Substance Abuse and Mental Health Services Administration (SAMHSA). 2003. The ADSS cost study: costs of substance abuse treatment in the specialty sector. DHHS Publication No. SMA 03-3762, Analytic Services A-20, Office of Applied Studies, Rockville, MD.
48. U.S. Department of Health and Human Services, National Institute on Drug Abuse. Drug Abuse Treatment Outcome Study (DATOS). 1991-1994 [United States] [Computer file]. Conducted by the Coordinating DATOS Research Center at the National Development and Research Institutes (NDRI), North Carolina, and collaborating research centers at Texas Christian University and the University of California at Los Angeles, with data collected by the Research Triangle Institute. ICPSR02258-v4. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor], 28 November 2007.
49. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). 2005 [Computer file]. Prepared by Synectics for Management Decisions, Incorporated. ICPSR04626-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor], 22 February 2007.
50. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. National Treatment Improvement Evaluation Study (NTIES), 1992-1997 [Computer file]. Conducted by National Opinion Research Center (NORC). 3rd ICPSR ed. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor], 2004.
51. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2002 [Computer file]. ICPSR03903-v3. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 26 October 2006. DOI: 10.3886/ICPSR03903.
52. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2003 [Computer file]. ICPSR04138-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 17 October 2006. DOI:0.3886/ICPSR04138.
53. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2004 [Computer file]. ICPSR04373-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 12 May 2006. DOI: 10.3886/ICPSR04373.
54. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2005 [Computer file]. ICPSR04596-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 12 August 2009. DOI: 10.3886/ICPSR04596.
55. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2006 [Computer file]. ICPSR21240-v4. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 12 August 2009. DOI: 10.3886/ICPSR21240.
56. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health, 2007 [Computer file]. ICPSR23782-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 12 August 2009. DOI: 10.3886/ICPSR23782.
57. U.S. Department of Justice. Bureau of Justice Statistics. Recidivism of Prisoners Release in 1994: [United States] [Computer file]. ICPSR03355-v6. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 9 February 2009. DOI: 10.3886/ICPSR03355.
58. U.S. Department of Justice, Bureau of Justice Statistics. Survey of inmates in state and federal correctional facilities, 2004 [Computer file]. ICPSR04572-v1. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor], 28 February 2007. DOI: 10.3886/ICPSR04572.
59. Wexler HK, Melnick G, Lowe L, Peters J., 1999. Three-year reincarceration outcomes for Amity in-prison therapeutic community and aftercare in California. The Prison Journal 79 (3): 321-336.
60. Williams RM., 1996. The costs of visits to emergency departments. The New England Journal of Medicine 334 (10): 642-646. (Pubitemid 26072123)
61. Wilson DJ., 2000. Drug use, testing, and treatment in jails. Bureau of Justice Statistics Special Report, NCJ 179999, U.S. Department of Justice, Office of Justice Programs, Washington, DC.
62. Winston WL., 1994. Operations Research: Applications and Algorithms (3rd edn). Duxbury Press: Belmont, CA.
63. Zarkin GA, Dunlap LJ, Hicks KA, Mamo D., 2005. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Economics 14: 1133-1150. (Pubitemid 41645377)